Content about Detoxification

January 12, 2012
Active Health Foods rolls out Active X bar for dialysis patients

Active Health Foods has introduced an energy bar designed for dialysis patients.

RIVERSIDE, Calif. — Active Health Foods has introduced an energy bar designed for dialysis patients.

The Active X double chocolate chip bar is made with an exclusive, proprietary formula and joins the company's current lineup of energy bars sold under the Active X and Active X Plus brands.

October 14, 2011
FDA approves treatment for iron overload

The Food and Drug Adminsitration has approved a drug made by ApoPharma for a complication resulting from treatments for a genetic condition that causes anemia, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Adminsitration has approved a drug made by ApoPharma for a complication resulting from treatments for a genetic condition that causes anemia, the agency said Friday.

The FDA announced the approval of Ferriprox (deferiprone), used to treat patients with iron overload due to blood transfusions for thalassemia, a blood disorder. Patients with the disease have excess iron in their bodies because of the frequent blood transfusions they must receive that can lead to iron overload, a condition that can be fatal.

October 25, 2010
Keryx to commence phase-3 trial for Zerenex

Drug maker Keryx Biopharmaceuticals has finished enrolling participants for a late-stage clinical trial of a...

NEW YORK Drug maker Keryx Biopharmaceuticals has finished enrolling participants for a late-stage clinical trial of a drug for patients on kidney dialysis, Keryx said Tuesday.

 

The company is conducting a phase-3 trial of Zerenex (ferric citrate) in patients with end-stage kidney disease on dialysis who have excessive phosphorous levels, a condition known as hyperphosphatemia.

 

 

Keryx said it expects to complete the study and report top-line data by the end of the year.

 

October 13, 2010
FDA issues warning over unapproved OTC chelation products

The Food and Drug Administration on Thursday warned eight companies that their over-the-counter chelation products...

September 28, 2010
Keryx commences phase-3 trial for Zerenex

Keryx has begun its phase-3 clinicial trial of a drug designed to treat elevated serum...

NEW YORK Keryx has begun its phase-3 clinicial trial of a drug designed to treat elevated serum phosphorous levels in patients with end-stage renal disease on dialysis.